Private Advisor Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.21M | Sell |
|
|||||
|
2025
Q1 | $3.61M | Buy |
|
|||||
|
2024
Q4 | $2.9M | Sell |
|
|||||
|
2024
Q3 | $3.37M | Sell |
|
|||||
|
2024
Q2 | $3.85M | Buy |
|
|||||
|
2024
Q1 | $3.33M | Sell |
|
|||||
|
2023
Q4 | $4.2M | Buy |
|
|||||
|
2023
Q3 | $3.42M | Sell |
|
|||||
|
2023
Q2 | $4.48M | Buy |
|
|||||
|
2023
Q1 | $1.93M | Sell |
|
|||||
|
2022
Q4 | $570K | Buy |
|
|||||
|
2022
Q3 | $1.68M | Sell |
|
|||||
|
2022
Q2 | $8.95M | Buy |
|
|||||
|
2022
Q1 | $7.73M | Sell |
|
|||||
|
2021
Q4 | $6.8M | Sell |
|
|||||
|
2021
Q3 | $5.78M | Buy |
|
|||||
|
2021
Q2 | $5.63M | Buy |
|
|||||
|
2021
Q1 | $2.48M | Buy |
|
|||||
|
2020
Q4 | $2.4M | Buy |
|
|||||
|
2020
Q3 | $2.51M | Buy |
|
|||||
|
2020
Q2 | $2.09M | Buy |
|
|||||
|
2020
Q1 | $1.18M | Buy |
|
|||||
|
2019
Q4 | $1.03M | Sell |
|
|||||
|
2019
Q3 | $996K | Buy |
|
|||||
|
2019
Q2 | $691K | Sell |
|
|||||
|
2019
Q1 | $845K | Buy |
|
|||||
|
2018
Q4 | $681K | Sell |
|
|||||
|
2018
Q3 | $995K | Buy |
|
|||||
|
2018
Q2 | $591K | Buy |
|
|||||
|
2018
Q1 | $399K | Sell |
|
|||||
|
2017
Q4 | $621K | Sell |
|
|||||
|
2017
Q3 | $921K | Buy |
|
|||||
|
2017
Q2 | $702K | Buy |
|
|||||
|
2017
Q1 | $607K | Buy |
|
|||||
|
2016
Q4 | $428K | Sell |
|
|||||
|
2016
Q3 | $453K | Sell |
|
|||||
|
2016
Q2 | $528K | Buy |
|
|||||
|
2016
Q1 | $377K | Sell |
|
|||||
|
2015
Q4 | $686K | Buy |
|
|||||
|
2015
Q3 | $530K | Sell |
|
|||||
|
2015
Q2 | $772K | Buy |
|
|||||
|
2015
Q1 | $609K | Buy |
|
|||||
|
2014
Q4 | $227K | Buy |
|